India's drug regulator has granted waivers for local trials, allowing Dr Reddy's and Emcure Pharmaceuticals to manufacture ...

Novo Nordisk India has launched the world's first once-weekly basal insulin, Awiqli, for adults with type 1 and type 2 diabetes. It reduces the injection burden from seven injections a week to just ...

India's Alkem Laboratories is all set to launch a semaglutide injection, meant for weight-loss and diabetes patients, priced merely at weekly cost of Rs 450 - making it one of the cheapest options ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...

Danish pharmaceutical major Novo Nordisk on Thursday launched its once-weekly basal insulin injection, Awiqli, in India for the treatment of diabetes in adults, marking the country's entry as the ...

HYDERABAD, India, April 3 (Reuters) - Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India. New Delhi ...